Immunomedics, Inc. (NASDAQ:IMMU)
Q4 2017 Earnings Conference Call
August 16, 2017 17:00 ET
Executives
Behzad Aghazadeh - Chairman
Michael Garone - Principal Executive Officer and Chief Financial Officer
Analysts
Jim Birchenough - Wells Fargo
Phil Nadeau - Cowen and Company
Matthew Andrews - Jefferies
Operator
Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to Immunomedics Inc. Fourth Quarter and Fiscal Year 2017 Results Conference Call. As a reminder, this call is being recorded. Today is Wednesday, August 16, 2017.
Before we begin, I would like to remind everyone that during this call the company will be making forward-looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. Such statements may involve significant risks and uncertainties. Actual results could differ materially from those expressed or implied on this call. For factors that could cause such differences, please refer to the company’s regulatory filings with the Securities and Exchange Commission most recently its annual report for the year ended June 30, 2017. The earnings report is available on the company’s website at www.immunomedics.com.
With us on the call today are Dr. Behzad Aghazadeh, Chairman of the Board of Directors of Immunomedics and Michael Garone, Principal Executive Officer and Chief Financial Officer of the company. Following their prepared remarks today, we will open the call up for questions.
At this time, I would like to turn the conference over to Dr. Aghazadeh.
